NCT04330027

Effectiveness of Lyophilized Growth Factors for Subacromial Impingement

Effectiveness of Lyophilized Growth Factors for Subacromial Impingement: Randomized Double Blind Placebo Controlled Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Alexandria University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to evaluate the efficacy of ultrasound-guided injection of platelet-derived lyophilized growth factors in treatment of subacromial impingement.

Detailed description

A new patented product named lyophilized Growth Factors has been developed. It is a novel advanced and refined form of conventional platelet-rich plasma. Effectiveness of intra-articular lyophilized Growth Factors injection has been studied in thirty patients with symptomatic primary knee osteoarthritis and has shown encouraging results regarding improvement of pain, stiffness and function in addition to decreasing knee effusion. The lack of good quality evidence to support the efficacy of injecting platelet-derived lyophilized growth factors in treatment of subacromial impingement highlights the need for thorough evaluation of the outcome of this novel therapeutic option in patients with subacromial impingement.

Conditions

• Shoulder Impingement Syndrome

Interventions

Type	Name	Description
BIOLOGICAL	Growth factors	A new patented product named lyophilized Growth Factors that is an advanced and refined form of conventional platelet-rich plasma
OTHER	Saline	0.9% Sodium Chloride

Timeline

• Start date: 2020-09-01
• Primary completion: 2021-04-01
• Completion: 2021-06-01
• First posted: 2020-04-01
• Last updated: 2020-07-09

Locations

1 site across 1 country: Egypt